Stereotactic Body Radiotherapy Using a Radiobiology-Based Regimen for Stage I Non-Small-Cell Lung Cancer: Five-Year Mature Results

Our first prospective SBRT study yielded reasonable local control and overall survival rates and acceptable toxicity. Refinement of the protocol including dose escalation may lead to better outcome.